We speculated that OI led to reduced secretion of LCN2, which induce appetite increase and excess energy intake through regulating the activity of feeding center of hypothalamus, then leading to obesity, insulin resistance, hyperglycemia, hyperlipidemia, and muscle dysfunction. The gene discussed is LCN2; the disease is hyperlipidemia.